Journal Article Summary
The article investigates the use of escitalopram, a medication commonly prescribed for anxiety and depression, to treat agitation in patients with Alzheimer’s dementia. Agitation is a frequent and challenging symptom of Alzheimer’s, often leading to distress for both patients and caregivers. While some medications have shown effectiveness in managing agitation, they can also pose risks, particularly regarding cognitive function and heart health. This study aims to determine whether escitalopram, when combined with psychosocial interventions, can safely and effectively reduce agitation in patients who do not respond to initial non-drug treatments.
The study involved 205 adults diagnosed with Alzheimer’s dementia who exhibited significant agitation. After a three-week period of psychosocial intervention, those who did not show improvement were randomly assigned to receive either escitalopram or a placebo for 12 weeks, while continuing the psychosocial support. The primary goal was to measure the proportion of participants who experienced a meaningful reduction in agitation. The results of this trial are still pending, with the final participant expected to complete the study by early 2024, and findings will be shared at a major conference.
There are some limitations to consider, including that the study is still ongoing, and results have not yet been published. Patients and caregivers should be aware that while escitalopram is widely used, its effects on agitation in Alzheimer’s patients are still being evaluated. It is important for individuals to discuss any concerns or questions about treatment options with their healthcare provider, especially regarding the potential benefits and risks associated with using escitalopram for managing agitation.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rajji Tarek K, Baksh Sheriza, Shade David, Ismail Zahinoor, Burhan Amer M., Okhravi Hamid, Padala Prasad R, Rosenberg Paul B., et al.. Escitalopram for Agitation in Alzheimer’s Dementia. Alzheimer's & Dementia 2025. DOI: 10.1002/alz.085738. PMCID: PMC11712352.
Featured Pill Pals Product
Citalopram 10 mg Tablets --- Generic For Celexa --- Mylan
Citalopram 10 mg Tablets — Generic For Celexa — Mylan is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
